- Trends in parthenolide research over the past two decades: A bibliometric analysis
Jiye Liu et al, 2023, Heliyon CrossRef - The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy
Tao An et al, 2022, Drug Design, Development and Therapy CrossRef - Terpenoids’ anti-cancer effects: focus on autophagy
Chirine El-Baba et al, 2021, Apoptosis CrossRef - Plants as a Source of Anticancer Agents: From Bench to Bedside
Wamidh H. Talib et al, 2022, Molecules CrossRef - Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway
Liru Huang et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef - Microtubules as a target of antitumor drugs
M. A. Dodokhova et al, 2022, South Russian Journal of Therapeutic Practice CrossRef - Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma
Qi Wang et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef - A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment
Yongping He et al, 2024, Journal of Ethnopharmacology CrossRef - Natural Anticancer Agents: Their Therapeutic Potential, Challenges and Promising Outcomes
Savita Tauro et al, 2024, Current Medicinal Chemistry CrossRef - Chemotherapeutics
Yuri N. Clement, 2024, Pharmacognosy CrossRef - First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor
Wenjing Liu et al, 2022, Molecules CrossRef - Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma
Shuai Liu et al, 2023, BMC Cancer CrossRef